XRN vs. BNGO

Last updated Jun 23, 2026

XRN (Chiron Real Estate Inc.) and BNGO (Bionano Genomics, Inc.) are both stocks. XRN operates in REIT - Healthcare Facilities (Real Estate), while BNGO operates in Diagnostics & Research (Healthcare). Over the past 5 years, XRN returned -6.77%/yr vs -80.70%/yr for BNGO. At a 0.21 correlation, their price movements are largely independent.

Performance

XRN vs. BNGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chiron Real Estate Inc. (XRN) and Bionano Genomics, Inc. (BNGO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XRN achieves a 6.69% return, which is significantly higher than BNGO's -24.84% return.

XRN

• 1D: 0.37%
• 1M: -5.85%
• YTD: 6.69%
• 6M: 5.29%
• 1Y: 21.56%
• 3Y*: 0.33%
• 5Y*: -6.77%
• 10Y*: —

BNGO

• 1D: 0.00%
• 1M: -7.26%
• YTD: -24.84%
• 6M: -24.84%
• 1Y: -64.83%
• 3Y*: -85.42%
• 5Y*: -80.70%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XRN vs. BNGO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
XRN Chiron Real Estate Inc.	6.69%	-4.11%	-23.56%	27.91%	-42.38%	43.51%	5.76%	59.98%	-3.48%
BNGO Bionano Genomics, Inc.	-24.84%	-91.16%	-84.74%	-87.05%	-51.17%	-2.92%	148.39%	-76.34%	-47.60%

Correlation

The correlation between XRN and BNGO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Sep 21, 2018	0.21

Over the past year, the correlation between XRN and BNGO has dropped to 0.01 - well below their long-term average of 0.21, suggesting their price drivers have been diverging.

Fundamentals

EPS XRN : -$0.76 BNGO : -$6.55
PS Ratio XRN : 2.96 BNGO : 0.19
Total Revenue (TTM) XRN : $158.29M BNGO : $22.06M
Gross Profit (TTM) XRN : $4.76M BNGO : $3.32M
EBITDA (TTM) XRN : $65.81M BNGO : -$23.09M

Return for Risk

XRN vs. BNGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XRN

XRN Risk / Return Rank: 62
XRN Sharpe Ratio Rank: 65
XRN Sortino Ratio Rank: 58
XRN Omega Ratio Rank: 59
XRN Calmar Ratio Rank: 64
XRN Martin Ratio Rank: 65

BNGO

BNGO Risk / Return Rank: 12
BNGO Sharpe Ratio Rank: 9
BNGO Sortino Ratio Rank: 11
BNGO Omega Ratio Rank: 8
BNGO Calmar Ratio Rank: 10
BNGO Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XRN vs. BNGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Chiron Real Estate Inc. (XRN) and Bionano Genomics, Inc. (BNGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XRN	BNGO	Difference
Sharpe ratio: Return per unit of total volatility	0.70	-0.80	+1.50
Sortino ratio: Return per unit of downside risk	1.12	-1.10	+2.22
Omega ratio: Gain probability vs. loss probability	1.15	0.83	+0.32
Calmar ratio: Return relative to maximum drawdown	1.07	-0.83	+1.91
Martin ratio: Return relative to average drawdown	2.54	-1.04	+3.58

XRN vs. BNGO - Sharpe Ratio Comparison

The current XRN Sharpe Ratio is 0.70, which is higher than the BNGO Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of XRN and BNGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XRN vs. BNGO - Drawdown Comparison

The maximum XRN drawdown since its inception was -58.92%, smaller than the maximum BNGO drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for XRN and BNGO.

Drawdown Indicators

	XRN	BNGO	Difference
Max Drawdown Largest peak-to-trough decline	-58.92%	-99.99%	+41.07%
Max Drawdown (1Y) Largest decline over 1 year	-20.21%	-77.85%	+57.64%
Max Drawdown (3Y) Largest decline over 3 years	-39.20%	-99.72%	+60.52%
Max Drawdown (5Y) Largest decline over 5 years	-58.92%	-99.98%	+41.06%
Current Drawdown Current decline from peak	-44.38%	-99.99%	+55.61%
Average Drawdown Average peak-to-trough decline	-23.50%	-85.27%	+61.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.52%	62.38%	-53.86%

Volatility

XRN vs. BNGO - Volatility Comparison

The current volatility for Chiron Real Estate Inc. (XRN) is 7.64%, while Bionano Genomics, Inc. (BNGO) has a volatility of 10.24%. This indicates that XRN experiences smaller price fluctuations and is considered to be less risky than BNGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XRN	BNGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.64%	10.24%	-2.60%
Volatility (6M) Calculated over the trailing 6-month period	21.81%	44.87%	-23.06%
Volatility (1Y) Calculated over the trailing 1-year period	31.08%	80.99%	-49.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.87%	89.81%	-60.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.20%	191.30%	-157.10%

Dividends

XRN vs. BNGO - Dividend Comparison

XRN's dividend yield for the trailing twelve months is around 6.87%, while BNGO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
BNGO Bionano Genomics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XRN Chiron Real Estate Inc.	6.87%	9.78%	10.88%	7.57%	8.86%	4.62%	6.13%	6.05%	9.00%	9.76%	4.48%

Financials

Frequently Asked Questions

Can I hold both XRN and BNGO in my portfolio?

XRN and BNGO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XRN or BNGO?

BNGO has higher volatility (10.24%) compared to XRN (7.64%). In terms of maximum drawdown, XRN dropped -58.92% vs BNGO's -99.99%.

Which has better risk-adjusted returns?

XRN currently has the higher Sharpe Ratio (0.70 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.